Acceptance and effectiveness of a web-based intervention for people with depressive symptoms waiting for outpatient psychotherapy: A randomized controlled trial
Not Applicable
- Conditions
- depressive symptoms
- Registration Number
- DRKS00010282
- Lead Sponsor
- Abt. für Rehabilitationspsychologie und Psychotherapie, Institut für Psychologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 136
Inclusion Criteria
1. internet access
2. depressive symptoms (Center for Epidemiologic Studies Depression Scale; CES-D score > 22)
Exclusion Criteria
Suicidal ideation (Brief Symptom Inventory; BSI item no. 9 > 1)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is the change of depressive symptoms severity, measured by the Center for Epidemiologic Studies Depression Scale (CES-D), between baseline (t1) and post-intervention (t2, seven weeks after randomization). Additionally, severity of depressive symptoms will be assessed 3 months after t2.<br>
- Secondary Outcome Measures
Name Time Method 1. Severity of depressive symptoms (categorical), measured using the Patient Health Questionnaire (PHQ-9)<br>2. Psychological symptoms, measured using the Brief Symptom Inventory (BSI)<br>3. Quality of life, measured using the SF-12 Health Survey<br>4. Attitude towards face-to-face therapy, measured using the Attitude Towards Seeking Professional Psychological Help-Scale (ATSPPH), including motivation and need for psychotherapy<br>5. Attitude towards web-based interventions, measured using an adapted version of the Attitude Towards Seeking Professional Psychological Help-Scale (ATSPPH).<br>All assessments take place at baseline (t1), seven weeks after randomization (t2), and at 3-months follow-up (t3).<br>Additionally, sociodemographics and internet affinity (IAS) will be assessed at baseline. At post-intervention, received health care (FIMA), intervention satisfaction (CSQ-8), and adverse events (INEP) will be assessed.